GlassScriptPhysician profile
Soroush Ghaffarpour
NPI 1578111357
$5,609.17
in general payments reported to CMS, 2019-2025
11 companies · $3,491 in 2025
The $3,491 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $319 · 2023: $795 · 2024: $1,004 · 2025: $3,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,600 · Travel and Lodging: $2,364 · Education: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,600.28 |
| Travel and Lodging | $2,364.27 |
| Education | $326.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $3,625.70 | 2023-2025 | |
| Dentsply Sirona INC | $529.72 | 2023-2025 | Surefil Sdr Flow+ Bulk Fill Flowable, Cavitron |
| Henry Schein, INC. | $509.57 | 2024-2025 | Adec INC Newtron Slim 61 Kit |
| Straumann USA LLC | $315.06 | 2025 | |
| 3m Company | $275.23 | 2021 | |
| Ivoclar Vivadent, INC. | $165.65 | 2024 | Cervitec |
| Kuraray America INC. | $49.13 | 2025 | |
| Align Technology, INC. | $45.81 | 2024 | Invisalign |
| Zimmer Biomet Holdings, INC. | $43.35 | 2021 | |
| Solventum Corporation | $25.61 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Envista Holdings Corporation | $24.34 | 2025 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soroush Ghaffarpour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.